[In vitro study, in vivo testing and clinical experience with the local antimycotic agent Ovis].
D000362:Agar; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects / Q000254:growth & development*; D003470:Culture Media; D003881:Dermatomycoses / Q000188:drug therapy*; D004821:Epidermophyton / Q000187:drug effects / Q000254:growth & development*; D006168:Guinea Pigs; D006801:Humans; D010783:Photometry; D014005:Tinea / Q000188:drug therapy; D014249:Trichophyton / Q000187:drug effects / Q000254:growth & development*
D000935:Antifungal Agents; D003470:Culture Media; D000362:Agar
In-vitro-Untersuchung, in-vivo-Prüfung und klinische Erfahrung mit dem likalen Antrimykotikum Ovis.